WF_Marketing_Masthead.png
How Vertex helps businesses manage the complexities of international taxation
December 13, 2019 05:00 ET | World Finance
LONDON, Dec. 13, 2019 (GLOBE NEWSWIRE) -- The global digital economy (GDE) changes rapidly; too fast for some. Over the last few years, it has become evident that tax regulation in its current form...
WF_Marketing_Masthead.png
Vertex provides help to businesses struggling with tax compliance in the digital age
November 13, 2019 05:00 ET | World Finance
LONDON, Nov. 13, 2019 (GLOBE NEWSWIRE) -- It’s often said that there are only two certainties in life: death and taxes. But just because taxation is unavoidable, doesn’t mean it is necessarily...
arbor-logo-tree-color.png
Arbor Biotechnologies Announces New Discoveries and Addition to its Board
January 03, 2019 08:58 ET | Arbor Biotechnologies Inc
Discovers three new CRISPR-Cas systems, findings published in the journal ScienceAppoints Paul Meister to its Board of Directors CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Arbor...
WF_Marketing_Masthead.png
The importance of rethinking tax policies to meet the changing requirements of the digital age
September 12, 2018 05:37 ET | World Finance
LONDON, Sept. 12, 2018 (GLOBE NEWSWIRE) -- In the digital era, tax authorities are aggressively pursuing new ways of capturing revenue. While new digital economy taxation proposals put forward by...
WF_Marketing_Masthead.png
Executives must understand the strategic importance of tax functions in order to prosper in an ever-changing global tax environment
August 20, 2018 05:00 ET | World Finance
LONDON, Aug. 20, 2018 (GLOBE NEWSWIRE) -- While the global tax policy environment continues to change at a dizzying pace, technological advances are simultaneously transforming the sector. ...
INVESTORS SAY EXECUTIVE PAY PACKAGES AT PHARMA MAY INCENTIVIZE DRUG PRICING RISKS
December 13, 2017 13:13 ET | Azzad Funds
Falls Church, Dec. 13, 2017 (GLOBE NEWSWIRE) -- SOURCE - AZZAD ASSET MANAGEMENT Investors today announced they have filed resolutions at five major pharmaceutical companies asking for information...
Parion Sciences Announces Upcoming Presentations of Data at the North American Cystic Fibrosis Conference Being Held October 8 through 10, 2015
October 05, 2015 08:12 ET | Parion Sciences
Data From Preclinical and Clinical Research on P-1037(VX-371) to be PresentedAdditional Data Presentation Includes a Review of a Novel in Silico Approach Towards Identification of CFTR...
CLEAN-CF Clinical Trial Expanded to Include Pediatric Cystic Fibrosis Population
September 10, 2015 09:35 ET | Parion Sciences
DURHAM, N.C., Sept. 10, 2015 (GLOBE NEWSWIRE) -- Parion Sciences, a company dedicated to the development of novel treatments for pulmonary and ocular diseases, announced today that the CLEAN-CF...
Vertex
Vertex and Parion Sciences Establish Collaboration to Develop Epithelial Sodium Channel (ENaC) Inhibitors in Cystic Fibrosis and Other Pulmonary Diseases
June 04, 2015 16:01 ET | Parion Sciences
-ENaC inhibition aims to restore or improve hydration of cell surfaces in the lungs to improve lung function- -Parion to receive $80 million up-front payment with potential for additional development...